120 related articles for article (PubMed ID: 2023608)
1. Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism).
Walker JL; Ginalska-Malinowska M; Romer TE; Pucilowska JB; Underwood LE
N Engl J Med; 1991 May; 324(21):1483-8. PubMed ID: 2023608
[No Abstract] [Full Text] [Related]
2. Effects of recombinant insulin-like growth factor I on IGF binding proteins and the acid-labile subunit in growth hormone insensitivity syndrome.
Walker JL; Baxter RC; Young S; Pucilowska J; Clemmons DR; Underwood LE
Growth Regul; 1993 Mar; 3(1):109-12. PubMed ID: 7683514
[No Abstract] [Full Text] [Related]
3. Treatment with recombinant human insulin-like growth factor I of children with growth hormone receptor deficiency (Laron syndrome). Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
Wilton P
Acta Paediatr Suppl; 1992 Sep; 383():137-42. PubMed ID: 1281024
[TBL] [Abstract][Full Text] [Related]
4. Acute response to recombinant insulin-like growth factor I in a patient with Mendenhall's syndrome.
Quin JD; Fisher BM; Paterson KR; Inoue A; Beastall GH; MacCuish AC
N Engl J Med; 1990 Nov; 323(20):1425-6. PubMed ID: 2233914
[No Abstract] [Full Text] [Related]
5. Effect of acute administration of insulin-like growth factor I in patients with Laron-type dwarfism.
Laron Z; Klinger B; Erster B; Anin S
Lancet; 1988 Nov; 2(8621):1170-2. PubMed ID: 2903379
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I treatment of children with Laron syndrome (primary growth hormone insensitivity).
Laron Z
Pediatr Endocrinol Rev; 2008 Mar; 5(3):766-71. PubMed ID: 18367997
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and hormonal changes induced by one week of administration of rIGF-I to patients with Laron type dwarfism.
Laron Z; Klinger B; Jensen LT; Erster B
Clin Endocrinol (Oxf); 1991 Aug; 35(2):145-50. PubMed ID: 1934530
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factors and their binding proteins in patients with growth hormone receptor deficiency: suggestions for new diagnostic criteria. The Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
Blum WF; Ranke MB; Savage MO; Hall K
Acta Paediatr Suppl; 1992 Sep; 383():125-6. PubMed ID: 1281023
[No Abstract] [Full Text] [Related]
9. Pharmacodynamics of a continuous intravenous infusion of CGP-35126 recombinant human insulin-like growth factor-I (rhIGF-I) on glucose and insulin levels in healthy males.
Morgan JM; Piraino AJ; Saris SD; Capuzzi DM
Int J Clin Pharmacol Ther; 1994 May; 32(5):235-9. PubMed ID: 7921517
[TBL] [Abstract][Full Text] [Related]
10. Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient.
Laron Z
J Clin Endocrinol Metab; 1995 May; 80(5):1526-31. PubMed ID: 7744997
[TBL] [Abstract][Full Text] [Related]
11. The chronicle of growth hormone receptor deficiency (Laron syndrome).
Rosenbloom AL
Acta Paediatr Suppl; 1992 Sep; 383():117-20. PubMed ID: 1458005
[No Abstract] [Full Text] [Related]
12. A child with phenotypic Laron dwarfism and normal somatomedin levels.
Pintor C; Loche S; Cella SG; Müller EE; Baumann G
N Engl J Med; 1989 Feb; 320(6):376-9. PubMed ID: 2913494
[No Abstract] [Full Text] [Related]
13. The role of recombinant insulin-like growth factor I in the treatment of the short child.
Rosenbloom AL
Curr Opin Pediatr; 2007 Aug; 19(4):458-64. PubMed ID: 17630612
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic use of insulin-like growth factor I: lessons from in vivo animal studies.
Gluckman PD; Ambler GR
Acta Paediatr Suppl; 1992 Sep; 383():134-6. PubMed ID: 1458009
[No Abstract] [Full Text] [Related]
15. [From research of non-suppressible serum insulin activity to the clinical application of recombinant insulin-like growth factor (rhIGF-I)].
Froesch ER
Schweiz Med Wochenschr; 1995 Jul; 125(27-28):1326-35. PubMed ID: 7624742
[TBL] [Abstract][Full Text] [Related]
16. An update on Laron syndrome.
Laron Z
Arch Dis Child; 1993 Mar; 68(3):345-6. PubMed ID: 8466235
[No Abstract] [Full Text] [Related]
17. Consequences of not treating children with laron syndrome (primary growth hormone insensitivity).
Laron Z
J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1243-8; discussion 1261-2. PubMed ID: 11964019
[TBL] [Abstract][Full Text] [Related]
18. Growth restoration of insulin-deficient diabetic rats by recombinant human insulin-like growth factor I.
Scheiwiller E; Guler HP; Merryweather J; Scandella C; Maerki W; Zapf J; Froesch ER
Nature; 1986 Sep 11-17; 323(6084):169-71. PubMed ID: 3528867
[TBL] [Abstract][Full Text] [Related]
19. Growth and growth hormone therapy in subjects with mulibrey nanism.
Karlberg N; Jalanko H; Lipsanen-Nyman M
Pediatrics; 2007 Jul; 120(1):e102-11. PubMed ID: 17548484
[TBL] [Abstract][Full Text] [Related]
20. Laron syndrome due to a post-receptor defect: response to IGF-I treatment.
Laron Z; Klinger B; Eshet R; Kaneti H; Karasik A; Silbergeld A
Isr J Med Sci; 1993 Dec; 29(12):757-63. PubMed ID: 8300382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
